UTHEVER® NMN: The Only NMN to Receive EFSA Positive Safety Opinion for Novel Food
July 2026
Access the UTHEVER® NMN white paper to discover this anti-ageing ingredient’s technical advantages & official compliance documents, including FDA NDI clearance in the U.S. and a positive EFSA safety opinion in Europe – the first-ever EU official safety endorsement for NMN. Learn the recommended safe daily intake of NMN as assessed by regulatory authorities in the white paper. Next, UTHEVER® NMN will be added to the EU Novel Food list, helping brands accelerate early market entry with strong regulatory support.
This Technical Paper is brought to you by EffePharm Ltd.
Brain & Mental Health
dsm-firmenich and Nous to launch Koncentra globally for caffeine-free energy and focus
Koncentra, a new botanical ingredient targeting energy, focus, and mood enhancement formulas, is launching globally through a partnership between dsm-firmenich and its developer, Nous, an Italian functional food ingredient...
Brain & Mental Health
Gaming meets formulation: IMCD Group to showcase nutritious F&B concepts at IFT First 2026
IMCD Group will exhibit its range of nine exclusive food and beverage concept creations, zeroing in on the e-sports category at IFT First 2026 in Chicago, US (July 12–15). The company highlights the segment as one of the...
Brain & Mental Health
Clinical trial challenges omega-3 claims for cognitive function and Alzheimer’s risk
A study has found that omega-3 fish oil supplementation does not provide any meaningful benefits for memory, cognition, or brain changes related to Alzheimer’s disease. Even though supplementing with fish oil provides the...
